Issue 12-08-2014

Pace of change makes the future less clear

Changes within the executive ranks in the chain drug industry are coming at a faster pace these days than at any time in the industry’s history. Most recently, Walgreens announced a new chief merchant, as a former Sam’s Club merchant, Linda Filler, was appointed to fill a position that was once held by Vern Brunner

Track-and-trace will reshape Rx supply chain

Sweeping changes will begin to transform the pharmaceutical supply chain at the start of 2015, when the first provisions of the Drug Supply Chain Security Act take effect. The landmark legislation, which was enacted late last year, is intended to strengthen the integrity of the system that moves medications from drug manufacturers to distributors and

In brand marketing, relevance to consumer is critical

In a multipart series during 2014, our team is examining key product attributes and marketing tactics from two different perspectives — the retail buyer and the consumer/shopper. This objective picture of the two viewpoints should contribute to a product’s success at retail. In this column, we explore the ways promotion impacts buyer and shopper behavior.

Does ACA meet expectations for pharmacies?

The passage of the Patient Protection and Affordable Care Act in 2010 (ACA) promised fundamental changes in the American health care environment. In turn, many in the chain pharmacy community were intrigued, if not excited, about the potential growth in prescription utilization and expansion of medication therapy management that the ACA promised to bring. Yet,

How big data will disrupt role of community pharmacy

Can retail pharmacies beat other players to patient ­intimacy? Many pharmacy retailers understand that big data can improve business operations, enabling intimate consumer engagement and thereby driving bigger baskets and more door turns, along with healthier customers and margins. They see impacts almost completely confined to the income statement. Too few grasp the strategic ability